Product Code: ETC035804 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India anaesthesia drug market is projected to register a CAGR of 3.8% during the forecast period, 2025-2031. With an increasing number of surgeries and critical care procedures being conducted in India, there has been a growing demand for effective anaesthetics drugs that are safe and cost effective. Additionally, government initiatives to promote research & development activities in the areas of anaesthesiology has further led to new product launches by major players operating in this market.
? Increasing Number Of Surgeries And Critical Care Procedures: There is an increase in the number of surgical procedures such as orthopaedic surgery (arthroplasty), ophthalmic surgeries, cardiothoracic and neurosurgical operations due to advancements in medical technologies and increased awareness about healthcare among people. This factor will drive growth opportunities for mild sedative & general anaesthetic agents during the forecast period. .
? Growing Preference For Minimally Invasive Surgical Procedures: The adoption rate of minimally invasive surgical techniques such as laparoscopic surgery or robotic surgery is increasing globally owing to their advantages over traditional open surgery like faster recovery times with reduced hospital stays and lower postoperative complications leading to improved patient outcomes. These advanced technology based treatments require reliable administration of local anesthesia which will serve as a driving force for growth opportunities within this industry during the coming years.
? Introduction Of Advance Anaesthesia Delivery Systems: Major players are introducing advance delivery systems integrated with safety features that provide more flexibility while managing patients? response towards different types anesthetic drugs resulting into enhanced patient outcome along with improved efficiency at hospitals level . Moreover, these technological advances also offer better control on dosage levels which have resulted into higher acceptance rates amongst end users including doctors/surgeons thereby creating lucrative revenue pockets across India`s Anesthesia Drug Market.
High Cost Of Anesthesia Drugs & Equipment: Despite availability of various generic versions ,the high cost associated with branded products coupled with rising prices related equipment used render it difficult for end user base consisting private practitioners or small sized clinics making affordability challenging situation thereby posing threat on overall market expansion.
Focusing upon its ongoing efforts towards innovation & customer centric approach ,major players present across Indian Anasthesia Drug Industry include Fresenius Kabi AG , Hospira Inc.,Abbott Laboratories , Baxter International Inc., Johnson & Johnson Services Inc., Merck Group
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anaesthesia Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anaesthesia Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Anaesthesia Drug Market - Industry Life Cycle |
3.4 India Anaesthesia Drug Market - Porter's Five Forces |
3.5 India Anaesthesia Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Anaesthesia Drug Market Revenues & Volume Share, By Routes of Administration, 2021 & 2031F |
3.7 India Anaesthesia Drug Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 India Anaesthesia Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Anaesthesia Drug Market Trends |
6 India Anaesthesia Drug Market, By Types |
6.1 India Anaesthesia Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Anaesthesia Drug Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 India Anaesthesia Drug Market Revenues & Volume, By General , 2021-2031F |
6.1.4 India Anaesthesia Drug Market Revenues & Volume, By Local, 2021-2031F |
6.2 India Anaesthesia Drug Market, By Routes of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Anaesthesia Drug Market Revenues & Volume, By Inhalation, 2021-2031F |
6.2.3 India Anaesthesia Drug Market Revenues & Volume, By Injection, 2021-2031F |
6.2.4 India Anaesthesia Drug Market Revenues & Volume, By Other , 2021-2031F |
6.3 India Anaesthesia Drug Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 India Anaesthesia Drug Market Revenues & Volume, By General Surgery, 2021-2031F |
6.3.3 India Anaesthesia Drug Market Revenues & Volume, By Plastic Surgery, 2021-2031F |
6.3.4 India Anaesthesia Drug Market Revenues & Volume, By Cosmetic Surgery, 2021-2031F |
6.3.5 India Anaesthesia Drug Market Revenues & Volume, By Dental Surgery, 2021-2031F |
6.3.6 India Anaesthesia Drug Market Revenues & Volume, By Other, 2021-2031F |
7 India Anaesthesia Drug Market Import-Export Trade Statistics |
7.1 India Anaesthesia Drug Market Export to Major Countries |
7.2 India Anaesthesia Drug Market Imports from Major Countries |
8 India Anaesthesia Drug Market Key Performance Indicators |
9 India Anaesthesia Drug Market - Opportunity Assessment |
9.1 India Anaesthesia Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Anaesthesia Drug Market Opportunity Assessment, By Routes of Administration, 2021 & 2031F |
9.3 India Anaesthesia Drug Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 India Anaesthesia Drug Market - Competitive Landscape |
10.1 India Anaesthesia Drug Market Revenue Share, By Companies, 2024 |
10.2 India Anaesthesia Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |